Privia Health Group annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Privia Health Group Stock-Based Compensation Growth & History (PRVA)
Privia Health Group's stock-based compensation was $71.1M for fiscal 2025.
View full Privia Health Group company overviewPrivia Health Group annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $71.1M | $14.4M | +25.38% |
| 2024 | 2024-12-31 | $56.7M | $19.6M | +52.78% |
| 2023 | 2023-12-31 | $37.1M | −$30.3M | −44.92% |
| 2022 | 2022-12-31 | $67.4M | −$186.2M | −73.43% |
| 2021 | 2021-12-31 | $253.5M | $253.0M | +52282.44% |
| 2020 | 2020-12-31 | $484,000 | $277,000 | +133.82% |
| 2019 | 2019-12-31 | $207,000 | — | — |
Privia Health Group quarterly stock-based compensation
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $19.4M | $547,000 | +2.90% |
| Q1 2026 | 2026-03-31 | $21.9M | $4.1M | +23.22% |
| Q4 2025 | 2025-12-31 | $15.5M | $173,000 | +1.13% |
| Q3 2025 | 2025-09-30 | $19.0M | $3.9M | +25.63% |
| Q2 2025 | 2025-06-30 | $18.8M | $4.5M | +30.98% |
| Q1 2025 | 2025-03-31 | $17.8M | $5.9M | +49.45% |
| Q4 2024 | 2024-12-31 | $15.3M | $3.6M | +30.94% |
| Q3 2024 | 2024-09-30 | $15.1M | $4.3M | +39.86% |
| Q2 2024 | 2024-06-30 | $14.4M | $5.1M | +55.63% |
| Q1 2024 | 2024-03-31 | $11.9M | $6.5M | +121.22% |
| Q4 2023 | 2023-12-31 | $11.7M | $2.5M | +27.18% |
| Q3 2023 | 2023-09-30 | $10.8M | −$4.0M | −27.18% |
| Q2 2023 | 2023-06-30 | $9.2M | −$9.2M | −49.94% |
| Q1 2023 | 2023-03-31 | $5.4M | −$19.5M | −78.37% |
| Q4 2022 | 2022-12-31 | $9.2M | −$15.9M | −63.40% |
| Q3 2022 | 2022-09-30 | $14.8M | −$11.0M | −42.51% |
| Q2 2022 | 2022-06-30 | $18.5M | −$184.1M | −90.88% |
| Q1 2022 | 2022-03-31 | $24.9M | $24.8M | +24534.65% |
| Q4 2021 | 2021-12-31 | $25.1M | $24.9M | +20619.01% |
| Q3 2021 | 2021-09-30 | $25.8M | $25.7M | +21222.31% |
| Q2 2021 | 2021-06-30 | $202.6M | $202.4M | +167304.96% |
| Q1 2021 | 2021-03-31 | $101,000 | −$20,000 | −16.53% |
| Q4 2020 | 2020-12-31 | $121,000 | — | — |
| Q3 2020 | 2020-09-30 | $121,000 | — | — |
| Q2 2020 | 2020-06-30 | $121,000 | — | — |
| Q1 2020 | 2020-03-31 | $121,000 | — | — |
Privia Health Group stock-based compensation trends
Over the last five fiscal years, Privia Health Group's stock-based compensation increased from $484,000 to $71.1M, a change of $70.6M. The latest reported quarter, Q2 2026, shows $19.4M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Privia Health Group source filings ↗